ACRV logo

Acrivon Therapeutics, Inc. Common Stock

ACRV
Healthcare|Biotechnology|US
$1.61
+0.04 (+2.55%)
DCF Value
$0.96
Tangible Book / Share
$2.07
Cash / Share
$2.15
Next Earnings Report
Nov 12, 2026
EPS est. -$0.45 · Revenue est. $504.3K
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Acrivon Expands into Immunology and Inflammation with Acquisition of Phase 2-Ready Differentiated, Oral JAK1 Inhibitor ACR-525, and PKCθ Inhibitor Preclinical Program from Aqilion AB
Nov 6, 2026 · GlobeNewsWire
Acrivon to Present Late-Breaking Oral Plenary Presentation and Posters at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Nov 4, 2026 · GlobeNewsWire
Acrivon Announces Late-Breaking Oral Plenary Presentation of Early Phase 1/2 Clinical Results in AP3-Predicted Tumors for its First-in-Class WEE1/PKMYT1 Inhibitor ACR-2316 at the 38th EORTC-NCI-AACR Symposium
Oct 29, 2026 · GlobeNewsWire
Acrivon Advances ACR-7280, an Optimized, AP3-Enabled, Potential First-in-Class, Oral CDK11 Inhibitor Toward IND Filing in First Half of 2027
Oct 20, 2026 · GlobeNewsWire
Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference
Sep 2, 2026 · GlobeNewsWire
Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
Aug 31, 2026 · GlobeNewsWire
Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts
Aug 12, 2026 · GlobeNewsWire

SEC Filings (48)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 2026S-8Employee stock planDocumentIndex
Aug 12, 20268-KMaterial eventDocumentIndex
Aug 12, 202610-QQuarterly reportDocumentIndex
Jun 17, 20268-KMaterial eventDocumentIndex
May 22, 2026DEFA14AProxy / shareholder voteDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 13, 20268-KMaterial eventDocumentIndex
Apr 30, 2026ARSAnnual report to holdersDocumentIndex
Apr 30, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 30, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 23, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 23, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Mar 19, 2026S-8Employee stock planDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 19, 202610-KAnnual reportDocumentIndex
Mar 2, 20268-KMaterial eventDocumentIndex
Feb 27, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Nov 21, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 202510-QQuarterly reportDocumentIndex
Nov 13, 20258-KMaterial eventDocumentIndex
Sep 5, 20258-KMaterial eventDocumentIndex
Aug 13, 202510-QQuarterly reportDocumentIndex
Aug 13, 20258-KMaterial eventDocumentIndex
Aug 13, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jun 13, 20258-KMaterial eventDocumentIndex
Jun 4, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2025S-8Employee stock planDocumentIndex
May 14, 202510-QQuarterly reportDocumentIndex
May 14, 20258-KMaterial eventDocumentIndex
May 1, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Apr 25, 2025ARSAnnual report to holdersDocumentIndex
Apr 25, 2025DEFA14AProxy / shareholder voteDocumentIndex
Apr 25, 2025DEF 14AProxy / shareholder voteDocumentIndex